Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
38.0%
% of FTXH's 51 holdings also in FBT
63.3%
% of FBT's 31 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 3.7% | 4.1% | 3.7% |
|
GILEAD SCIENCES INC | 3.7% | 4.3% | 3.7% |
|
BIOGEN IDEC INC | 3.7% | 3.2% | 3.2% |
|
REGENERON PHARMACEUTICALS | 3.4% | 3.2% | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.6% | 2.9% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to FBT
|
BRISTOL-MYERS SQUIBB CO | 7.6% |
|
JOHNSON & JOHNSON | 7.5% |
|
ABBVIE INC | 7.4% |
|
MERCK & CO. INC. | 7.3% |
|
PFIZER INC | 7.2% |
|
ZOETIS INC | 3.7% |
|
VIATRIS, INC. | 3.5% |
|
ELI LILLY & CO | 3.4% |
 |
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
ORGANON & CO. | 2.6% |
FTXH Underweight Relative to FBT
|
BEIGENE LTD. SPONSORED ADR | -5.2% |
|
INTRA-CELLULAR THERAPIES INC | -4.8% |
|
VERTEX PHARMACEUTICALS INC | -3.6% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
|
CORCEPT THERAPEUTICS INC | -3.3% |
|
WATERS CORP | -3.3% |
 |
GENMAB A/S SPONSORED ADR | -3.1% |
 |
ARGENX SE ADR | -3.1% |
|
REPLIGEN CORP | -3.0% |